AGX is certainly one of the "safer" biotechs as it has pre-R & D EPS of around 3c to support the price from its other operations if Thromboview fails. Then you have huge upside if Thromboview comes off which does not appear to be priced in at all. That's not to say that if Thromboview fails that the price wouldn't get a whipping but the underlying earnings do provide some degree of safety compared to a one trick company.
I hold AGX..........
Ed.
- Forums
- ASX - By Stock
- CT1
- interesting
interesting, page-2
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $109 | 54.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 7443517 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 6778957 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7443517 | 0.002 |
29 | 22634991 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 6778957 | 8 |
0.004 | 4944996 | 5 |
0.005 | 2000000 | 1 |
0.007 | 2500000 | 2 |
0.008 | 1000001 | 1 |
Last trade - 15.52pm 18/10/2024 (20 minute delay) ? |
Featured News
CT1 (ASX) Chart |